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Executive Summary 
 
Evaluation scope  
Numerous efforts around the country are trying to identify practice models that can integrate 
primary care and mental health services with the goal of improving the accessibility, quality, and 
outcomes of services for persons with mental illnesses who present in general medical settings. Locally, 
the North Carolina Foundation for Advanced Health Programs, Inc., in collaboration with several 
community partners, developed a three-year (2006-09) demonstration to do this at four pilot sites 
across the state. The ICARE – Integrated, Collaborative, Accessible, Respectful, and Evidence-based – 
project was supported by grants from AstraZeneca,  the Kate B. Reynolds Charitable Trust and The Duke 
Endowment. This report presents results from an evaluation of the practice demonstration component 
of ICARE that was conducted by the Cecil G. Sheps Center for Health Services Research at the University 
of North Carolina at Chapel Hill. The evauation was funded by the Foundation and the North Carolina 
Division of Medical Assistance. The evaluation examined both the processes of implementing integrated 
care at the four pilot sites through interviews and surveys with practice staff as well as the outcomes of 
care through an analysis of Medicaid claims data. Other aspects of the ICARE project including technical 
assistance to the participating practices, statewide trainings of human service providers, and efforts to 
promote policy changes were addressed by separate evaluations. 
 
Main findings and conclusions 
1. Implementation of integrated care 
Surveys completed by staff at all four ICARE pilots indicated that, during the demonstration period, 
access to mental health care was improved by co-locating mental health providers within primary care 
practices, by decreasing the wait time between initial referral and a mental health appointment, by 
developing and implementing individualized care plans and clear lines of responsibility for follow-up, 
and by employing use of evidence-based diagnostic tools for depression and other psychiatric 
conditions.  
Practice staff felt that ICARE was a beneficial program and that it was helpful to have a mental 
health provider co-located in the primary care practice. Many staff also said that patients found 
integrated care in the doctor’s office to be less stigmatizing than going to a mental health clinic. Patients 
themselves reported often having difficulties communicating with primary care staff about their mental 
health needs and spoke positively about the co-located provider who explained treatments, reasons for 
prescribing medications, and medication side effects.  
Both practice staff and mental health clinicians agreed that communication between them had 
improved and that they became more aware of community mental health resources that their patients 
could access. Various challenges were also identified including difficulties in identifying mental health 
clinicians to co-locate, too few days of co-located provider time, not enough time in busy medical offices 
to implement treatment algorithms, and restrictions in billing for co-located providers which threatened 
the sustainability of these arrangements beyond ICARE grant funding.  
2. Outcomes of integrated care 
ICARE patients at the Phase 1 pilots (East and West) had a statistically significant 3%-11% decrease 
in Medicaid-reimbursable outpatient mental health service use per quarterly period relative to patients 
in practices that did not participate in ICARE, whereas ICARE patients at the Phase 2 pilots had a 4%-12% 
increase in these services relative to control patients. For the most part, the increased access for ICARE 
patients came with greater increases in average per patient Medicaid costs relative to control patients in 
other primary care practices.  
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3. Conclusions  
Staff and patients both saw improved access to mental health services and greater coordination 
between primary care and mental health providers during the ICARE integrated care demonstration. 
Pilot outcomes as reflected in Medicaid claims were more varied across the four pilots. The Phase 1 
pilots (East and West) showed small but significant decreases (3% - 11%) in Medicaid-reimbursed 
outpatient and ED service use.  Whereas the Phase 2 pilots (North Central and Southeast showed small 
but significant increases (4% - 12%) in Medicaid outpatient and ED service use. These differences might 
be associated with the role of co-located mental health providers and with shared learning among pilots 
which accelerated implementation and billings at Phase 2 pilots. 
 
Participating practices 
The demonstration was implemented in four regions of the state in two phases. The Phase 1 sites 
were operative from September 2006-June 08 in the Asheville (West, 4 practices) and January 2007-June 
2008 in Wilmington (East, 4 practices) areas; the Phase 2 sites were operative from September 2008-
June 2009 in the Lumberton (Southeast, 7 practices) and Henderson (North Central, 2-5 practices) areas. 
Each of the four pilots was encouraged to select from a menu of integration approaches for their 
respective target populations—adults with severe and persistent mental illness (West), youth and adults 
with any mental illness (East and Southeast), youth and adults with mental health and substance abuse 
disorders (North Central). As a result each pilot had a different configuration of interventions, although 
co-location of mental health providers and use of evidence-based screening protocols were common 
strategies.  
 
Evaluation methods 
The process evaluation relied upon a series of self-report measures that asked practice staff to 
identify the levels of integration between their primary care and mental health services prior to, early 
on, and later in the two-year implementation period. In addition interviews were conducted with key 
participants at each pilot site early on and later in this period. A patient focus group was also conducted 
at each pilot. 
The outcome evaluation relied upon a quantitative analysis of Medicaid claims data for each of the 
four pilot sites in comparison to all Medicaid patients in practices that did not participate in ICARE. A 
pre-post comparison group design was employed separately for each pilot site. Due to lag times in 
obtaining Medicaid paid claims data, the length of the post-period was limited to 12 months for Phase 1 
pilots (East and West) and to 9 - 10 months for Phase 2 pilots (Southeastern and North Central). 
Outcomes focused on Medicaid expenditures for five service categories: outpatient mental health, total 
outpatient, emergency department, psychotropic drugs, and total services. 
 
Implications 
The ICARE project was successful in demonstrating the receptivity and endorsement of primary care 
practices in different parts of the state to integrated care arrangements. Medicaid claims analyses 
showed mixed results of increased access and Medicaid expenditures at some pilots and decreased 
access at others. This evaluation was unable to determine whether increased access led to 
improvements in patient health status due to reliance only on Medicaid claims data and a relatively brief 
9-12 month follow-up period. Further, this evaluation was not able to assess the billing behaviors of 
participating clinicians or the longer-term sustainability of the integrated arrangements introduced at 
the primary care sites. Many of the participating practice staff, however, acknowledged that it would be 
unlikely for them to sustain integrated care under current Medicaid and other third-party 
reimbursement provisions. So although integrated care arrangements can be introduced into primary 
care practices, paying for them on an on-going basis is still a major problem. All of these issues remain 
important challenges to address in further efforts to integrate primary care and mental health services 
in North Carolina. 
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I. Introduction 
 
This is a critical time for mental health service delivery in North Carolina. Despite efforts begun in 
2001 to reform the public mental health system, the state lags behind most others in per capita 
expenditures on mental health and is currently experiencing a shortage of mental health providers.1 
State Medicaid agencies are faced with rising costs and budgetary reductions, public mental health 
services for many mentally ill populations are shrinking, and the burden of caring for patients with 
depression and other mental disorders is increasing on primary care practices across the state. 
Accordingly, there is a lot of interest and support for efforts to integrate primary care and mental health 
services to improve the accessibility, quality, and outcomes of care.  
 
Mental health disorders affect approximately one in four Americans or approximately 57 million 
people nationwide.2 Individuals with mental health disorders also experience comorbid physical 
conditions such as cardiovascular, pulmonary disease, diabetes, and arthritis. These individuals often 
use more health care services and have higher health care costs.3  In addition, individuals with mental 
health and physical comorbidities are more likely to see a primary care physician than a mental health 
provider. Literature shows that treatment of depressions and anxiety can be effectively treated in the 
primary care setting along with their comorbid physical health conditions.3  Unfortunately, primary care 
physicians often report feeling unprepared to diagnose or treat mental health disorders in the primary 
care setting.4-5 Other barriers to mental health integration also exist. Particularly, traditional delivery and 
payment structure of mental health and physical health services are often separate, leading to 
fragmented care for individuals receiving both mental and physical health services.6-7 Integration has the 
potential to increase collaboration between mental health and primary care providers, increasing the 
ability of primary care providers to provide high quality mental health care, and improving the ability of 
mental health providers to screen and refer patients for medical illness. 
 
Responding to these needs, the North Carolina Foundation for Advanced Health Programs, Inc. in 
collaboration with several professional associations and partner agencies (NC Psychiatric Association, NC 
Academy of Family Physicians, SR-Area Health Education Center, and NC Pediatric Society) initiated a 
pilot program to demonstrate and assess models of integrating primary care and mental health services. 
The ICARE – Integrated, Collaborative, Accessible, Respectful, and Evidence-based – project was 
supported by grants from AstraZeneca, the Kate B. Reynolds Charitable Trust and The Duke Endowment. 
This report prepared by the Cecil G. Sheps Center for Health Services Research at the University of North 
Carolina at Chapel Hill presents results from an evaluation of one component of the ICARE program, the 
integrated care demonstration at four primary care pilot sites. Other aspects of ICARE including 
technical assistance to the participating practices, statewide trainings of human service providers, and 
efforts to promote policy changes were addressed by other evaluations. 
 
Goals of ICARE Pilot Sites Demonstration 
The goals of the ICARE integrated care pilots were to improve outcomes for patients suffering from 
mental illness and co-occurring mental illness and substance abuse disorders by increasing 
communication and collaboration between primary care and mental health providers and enhancing 
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their capacity to both make informed treatment decisions and provide appropriate care. The ICARE pilot 
interventions operated from 2006 through 2009 with Phase 1 running from 2006-2008 and Phase 2 
running from 2007-2009. Four pilots composed of multiple primary care practices participated, two in 
each phase. Pilot sites had considerable flexibility in both the clinical population targeted and the ways 
services were integrated. Phase 1 sites were located in Western and Eastern North Carolina and Phase 2 
sites were located in North Central and Southeastern North Carolina. A detailed profile of the four pilots 
is presented in Section II of this report. 
 
Evaluation Scope 
This evaluation examined both the processes of implementing integrated care at the four pilot sites 
through interviews and surveys with practice staff as well as the outcomes of care through an analysis of 
Medicaid claims data. Summary findings from both the process and outcome components of the 
integrated care evaluation are presented in this report. Other aspects of ICARE including technical 
assistance to the participating practices, statewide trainings of human service providers, and efforts to 
promote policy changes fell outside the scope of this evaluation. 
The evaluation was conducted by the Cecil G. Sheps Center for Health Services Research at the 
University of North Carolina at Chapel Hill. The evauation was funded by the North Carolina Foundation 
for Advanced Health Programs, Inc. and the Division of Medical Assistance, North Carolina Department 
of Health and Human Services.  
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II. Process Evaluation 
 
The process evaluation focused on the activities that the pilot sites engaged in to integrate primary 
care and mental health services. Below we describe the characteristics of the four pilots, the methods 
used to assess the levels of integration achieved by each pilot during the ICARE demonstration, and the 
results of the process evaluation for each pilot.  
 
Pilot Sites 
A summary profile of the four pilot sites and the activities they engaged in to integrate primary care 
and mental health services is presented in Exibit 1.  Each of the four sites was encouraged to select from 
a menu of integration approaches for their respective target populations and local environments. As a 
result each pilot had a different configuration of interventions, although co-location of mental health 
providers and use of evidence-based screening and treatment protocols were common strategies. 
Highlights are presented below for each pilot. 
 
The Eastern Pilot (Pender and New Hanover counties) operated under Phase 1 of the ICARE 
demonstration. This pilot focused on adults, children, and adolescents with any mental health diagnosis. 
The intervention co-located one psychiatrist in four primary care practices (two community health 
clinics and two pediatric/family practices) one day per practice per month. Primary care providers 
identified and conducted initial screenings then referred patients to the co-located mental health 
provider. The co-located psychiatrist assessed and evaluated patients as well as conducting on-site and 
telephone consultations with primary care providers. This pilot also developed screening and treatment 
algorithms for anxiety and ADHD, mental health resources and phone lists for patients, and conducted 
targeted education for primary care providers. Once the ICARE demonstration ended, some Eastern 
Pilot practices received co-location funding from Community Care of North Carolina (CCNC) or private 
Community Support providers to continue these integration services.  
 
The Western Pilot (Buncombe and Henderson counties) operated under Phase 1 of the ICARE 
demonstration. This pilot focused on care management for adults with severe and persistent mental 
illness and high medical comorbidities. Participants had several years prior experience with care 
management for patients with depression and other psychiatric conditions in primary care practices and 
so had a shorter implementation learning curve than the other pilots. The site coordinator pre-identified 
target group patients through an analysis of Medicaid paid claims data for patients with chronic health 
conditions and mental health diagnoses. The intervention relied on two care managers (1 full-time and 1 
part-time) to provide case management services. Care managers acted as a link between the four 
participating primary care practices and specialty mental health providers and targeted case 
management for patients (i.e. in-person visits, home visits and telephone consultations). This pilot also 
developed treatment algorithms for bipolar disorder and conducted trainings with local stakeholders on 
mental health disorders and other planning and implementation efforts. After ICARE ended, case 
management services were transitioned to a co-location grant from Community Care of North Carolina 
or private Community Support providers. 
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The North Central Pilot (Vance, Franklin, Granville, and Warren counties) operated under Phase 2 
of the ICARE demonstration. This pilot focused on integration of substance abuse and mental health 
services in primary care. The intervention co-located one licensed social worker in three participating 
primary care practices (reduced to only two practices in year 2) for a total of four days per week. This 
person also served as the ICARE site coordinator. The social worker provided participating primary care 
practices with new screening tools, mental health referral forms and resources, consultations, and 
patient follow-up.  
 
The Southeastern Pilot (Robeson county) operated under Phase 2 of the ICARE demonstration. This 
pilot focused on children, adolescents, and adults with any mental health diagnosis. The intervention co-
located two physchiatrists (one adult psychiatrist and one child psychiatrist), four licensed social 
workers, and two licensed professional counselors in seven practices (five hospital based practices and 
two pediatric practices). The ICARE coordinator then served as the link between the mental health 
provider and primary care physician by informing the primary care provider where a patient was seeking 
mental health treatment and the type of treatment the patient received. She also served as a central 
contact point for patients. This pilot conducted targeted education and trainings for primary care staff, 
created a local advisory group, and a training manual on crisis management. This site received co-
location funding from Community Care of North Carolina (CCNC) which overlapped with the ICARE pilot 
site demonstration.  
10 
 
Exhibit 1: Summary Profile of ICARE Pilot Sites 
 Phase 1 Phase 2 
 East West North Central Southeast 
Location (county) Pender and New Hanover Buncombe and Henderson Vance, Franklin, Granville, and 
Warren 
Robeson 
Number  of 
Practices 
4 4 3
a 
7 
Total Patients in 
Practices 
20,980 38,187 6,644 23,841 
Target Population Adult and Pediatric Adult Adult and Pediatric Adult and Pediatric 
Target Diagnosis 
All mental health diagnoses SPMI with High physical health 
needs 
b
 
Substance Use, Depression, 
Anxiety 
c
 
All mental health diagnoses 
Type of Co-located 
Provider 
Psychiatrists Care managers Licensed social worker Psychiatrists and Behavioral 
Health Specialists 
Integrated Care 
Activities 
Educated primary care providers 
on guidelines for 
screening/treatment of adult 
anxiety and ADHD in children 
On-site mental health 
assessment, consultation and 
treatment and telephone 
consultation to primary care 
Developed treatment algorithms 
on anxiety and ADHD, and 
resource tools and phone 
numbers for patients 
Targeted case management 
including in-person and home 
visits and telephone 
consultation 
Round table sessions for 
stakeholders on communication, 
cross-training, and 
planning/implementation 
efforts 
Trained on Depression, Bipolar 
and Metabolic Syndrome 
Developed of treatment 
algorithm for Bipolar disorder 
Trained PCP in screening and 
evidence-based practice for 
mental health disorders. 
Trained local mental health and 
primary care stakeholders on 
Domestic Violence, Edinburg 
Postnatal Depression Scale, and 
referral process for mental 
health services in primary care 
Created specialized consent 
forms and encounter tracking 
tools 
Provided case management/ 
coordination to ensure 
continuity of care and feedback 
to primary care 
Created local advisory group on 
mental health and primary care 
oversight, training and 
education.  
Developed training manual for 
use of crisis management 
services and disseminated to 
primary care practices 
a 
Began with 3 ICARE funded practices in 1
st
 year, but reduced to 2 practices in June 2008 
b 
Quadrant IV (Hi Mental Health/ Hi Medical Needs) of the Four Quadrant Model 
8
 
c 
Quadrant I (Lo Mental Health/Lo Medical) of the Four Quadrant Model 
8 
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Methods 
Four data collection activities were used in the process evaluation to measure the activities 
undertaken to integrate care at each pilot site and to assess changes in the levels of integration at each 
pilot site during the ICARE demonstration period. 
 
Dimensions of Integration Survey (DIS): The DIS (see Appendix D) is a self-rating by staff at each 
ICARE practice on multiple dimensions of mental health-primary care integration. These ratings 
described starting and ending points at each practice with regard to the multiple ways clinical services 
and supporting activities were used to foster integration. Eight dimensions were assessed at three 
points in time: treatment patterns, use of clinical algorithms and best practices, crisis assessment 
services, physical proximity, temporal proximity, communication, patient care, and appropriate care. 
The DIS was completed in a group interview with primary care practice staff. Group interviews included 
at least three members of the primary care practice with at least one primary care physician, the co-
located mental health provider, and one other member of the primary care office staff. The use of group 
interviews to complete the survey was meant to capture consensus impressions within the practice on 
each question. Practices completed the DIS at three points in time at six-month intervals. Analysis of 
survey responses focused on changes in the levels of integration  
 
Integration Activities Assessment (IAA): The IAA (see Appendix E) was completed by each ICARE 
pilot site as part of their quarterly reports. The purpose was to capture the type and frequency of 
activities that reflected the integration of primary care and behavioral health at each pilot. Activities 
included number of patients treated, number of consultations between behavioral health providers and 
primary care staff, and time spent by behavioral health providers on-site. ICARE sites submitted counts 
of these contacts on a quarterly basis during the 2007-2008 fiscal years.  
 
Semi-Structured Interviews (SSI): The purpose of the SSI (see Appendix F) was to assess stakeholder 
experiences and perceptions towards the end of the two-year pilot regarding ICARE implementation, 
pilot accomplishments, and barriers. Four stakeholders from each pilot participated in individual 30-
minute interviews at one point in time towards the end of the pilot. Stakeholders included a primary 
care provider, mental health provider, ICARE coordinator, and a primary care office staff member. 
Stakeholders provided their perceptions about the distinctive model employed at each site, changes 
that occurred to the model or its themes in the implementation, and major barriers and facilitators of 
change related to the ICARE project. Interviews were summarized by strengths, weaknesses, and 
limitations of the ICARE project reported by two or more respondents at each pilot.  
 
Patient Focus Groups: The purpose of the patient focus group was to assess patient perceptions of 
the care received, how their behavioral and physical health needs were addressed, and their overall 
satisfaction with care (see Appendix G). Flyers were mailed to each patient who visited an ICARE 
provider during the pilot inviting their participation in the patient focus group. Two sites included 
child/adolescent target populations; therefore, parents/caregivers were invited to participate on behalf 
of their child. Two focus groups were conducted for each pilot site. Due to a delayed start for the 
evaluation, the first focus group occurred approximately a year and a half after start-up for the Phase 1 
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(November 2007/January 2008) pilots and approximately nine months after start-up for the Phase 2 
pilots (March/April 2008). The follow-up focus group occurred approximately six months after the first 
focus group during the final month of the pilot for Phase 1 and the follow-up focus group occurred in 
November/December 2008 for Phase 2. 
 
Results 
For the most part, these findings on implementation process have been previously reported to the 
Foundation and the Division of Medical Assistance. They are highlighted and summarized here to 
provide a context for the outcome evaluation of ICARE which is presented in Section III of this report.  
Dimensions of Integration: The results presented here focus on four elements of the eight 
dimensions of integration captured in the surveys: temporal proximity, patient care, follow-up 
responsibility, and clinical algorithms/best practices. These four dimensions are key elements of 
integrated care as discussed in the literature. 
The temporal proximity dimension (Exhibit 2) represents the typical time between the primary care 
physician’s initial referral and the patient’s first visit with the co-located mental health provider. All 
ICARE pilot sites improved in this dimension as exhibited by the decrease in time between the initial 
referral and the mental health appointment. Each of the ICARE pilots, except the West, significantly  
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reduced their time between appointments from having no co-located provider or having more than 
three months between appointments to approximately 1-2 weeks between appointments. The West 
pilot had the least room for improvement on this dimension because, at the outset of the 
demonstration, they were already at “only 1 day between visits” and they could only improve to “same 
day visits”. This profile suggests that, across all sites, the ICARE demonstration did improve patient 
access to mental health providers by co-locating providers within primary practices. 
 
The patient care dimension (Exhibit 3) represents information on individualized care plans, care 
plan implementation, and follow-up responsibility. Exhibit 4 specifically shows the results of who took 
responsibility for implementing the individualized care plan. The East and Southeast sites took a mental 
health and primary care provider joint responsibility approach to implementing the plan, which was a 
change for these sites from having no care plan at all at the first survey point. As with Exhibit 3, the 
Western pilot already had experience with co-location and a shared responsibility approach at the 
outset of the demonstration, but with the start of the ICARE demonstration, the mental health provider 
took the primary role in implementation. The North Central site ended up with the primary care 
provider taking full responsibility for implementing the care plan, an arrangement that was consistent 
with difficulties in recruiting a mental health provider.  
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One aspect of the communication dimension is follow-up feedback (Exhibit 4) which reflects the 
frequency with which the co-located mental health provider gave feedback to the primary care provider 
about the recommended treatment plan. The East and Southeast exhibited the greatest improvements 
over the three survey points by going from feedback none of the time to 81-100% of the time. As with 
the previously discussed dimensions, the results in the North Central site were affected by their 
challenges with finding co-located mental health providers for the primary care practices. The second 
survey point was the only time during the evaluation period when there was a co-located provider 
consistently in the practices and, as with the previous exhibits, was the survey point where we observed 
the most improvement in follow-up feedback on the recommended treatment plan. 
 
 
The clinical algorithms/best practices dimension (Exhibit 5) represents the frequency that primary 
care providers utilized a published evidence-based diagnostic tool for an array of disorders. Figure 4 
reflects the frequency that primary care providers used an evidence-based diagnostic tool for 
depression. Three of the four pilot sites increased their use of evidence-based diagnostic tools for 
depression by the final survey point. The Western and Southeastern sites increased their use of these 
tools to 61-80% of the time while the Eastern site increased their use to 41-60% of the time. Some sites 
described the use of the evidence-based tools as too cumbersome for a brief intervention or 15 minute 
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office visit, which may have limited the use of the tools. At the North Central site, there was an increase 
in the use of the tools in the second survey point to 41-60% of the time, however, when the third survey 
was taken, the site was experiencing turnover of the co-located mental health provider and may have 
affected the use of evidence-based tools. 
 
Participant Interviews: Overall, stakeholders at each pilot discussed many of the same strengths, 
but the limitations show the unique challenges each of the pilots faced in implementing integrated care 
(Exhibit 7). Most all of the stakeholders said that (1) the ICARE demonstration was a beneficial program  
 
and (2) it was helpful to have a mental health provider co-located in the primary care practice. 
Stakeholders in the East, North Central, and Southeast pilots said that it decreased the stigma of mental 
health by accessing mental health services though the primary care provider’s office since it was a place 
they were already familiar with and had a trusting relationship with the primary care provider. From the 
provider perspective, ICARE increased knowledge of mental health services, and community mental 
health resources to primary care physicians and their staff that did not exist prior to ICARE. Primary care 
offices were given resources about the LME, crisis information, and clinical guidelines that they were not 
aware of previously. Further, stakeholders said that ICARE helped to improve the communication 
between the primary care provider, mental health provider, and case manager that had not occurred 
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previously. At some sites, ICARE case managers were able to communicate in real time with the primary 
care providers and, thereby, were able to connect primary care providers with community resources 
regarding specialty mental health services. 
 
While there was agreement across the sites about the strengths of the ICARE efforts to integrate 
care, there was less agreement about limitations. However, one limitation discussed by nearly all 
stakeholders at all sites was concern about sustainability. Stakeholders discussed the need for 
continuous funding because “. . . it took up to six to nine months to start a program, but when funding 
ends, the program ends as well.” They all spoke to the problems of trying to maintain a nucleus of 
support without funding or a way for billing integrated services once the pilot project ended. Another 
common challenge was finding mental health providers to co-locate in the primary care practices. In the 
East, a rural/suburban area, the co-located provider was not available frequently enough which limited 
her ability to see patients often enough and, in turn, this limited the primary care physician’s ability to 
utilize the co-located provider’s services. By the time the co-located provider was available, the primary 
care provider had already addressed issues with other resources or referrals. At the North Central site, a 
rural/suburban area, finding a co-located provider proved to be one of their most significant challenges. 
The ICARE coordinator, who was also a licensed social worker, ended up serving as both the coordinator 
and co-located provider because they could not find anyone to serve as the co-located provider. She had 
to discontinue services to all three of North Central’s practices as the co-located provider in August 2008 
because of her excessive workload. In her absence, a backup served one of the practices. 
 
Exhibit 7: Strengths and Limitations of ICARE Pilot Sites Demonstration Identified in Semi-Structured  
Interviews with Stakeholders a 
 Phase 1 Phase 2 
 East West North Central Southeast 
 
 
 
 
 
 
Strengths 
Educated primary care 
providers and staff about 
mental health services 
and use  
Helpful to have person 
co-located in the office 
ICARE case manager was 
able to access and 
update electronic 
medical record 
Improved 
communication between 
case managers, primary 
care providers and 
mental health providers 
Improved care – patients 
only need to visit one 
office for primary care 
and mental health care in 
an environment they 
were already familiar 
Primary care has new 
directory of community 
mental health services  
Innovative, beneficial 
program that helped 
identify patients at an 
earlier stage of illness 
Bi-monthly collaboration 
team meetings to 
address concerns and 
implementation issues 
Educated providers on 
community mental 
health resources  
 
 
 
 
 
 
 
 
 
Co-located mental health 
provider not often 
available enough  
Clinical guidelines/ 
algorithms were too 
complicated and 
cumbersome  
Confusion about the 
programs, referrals and 
which patients belong in 
ICARE 
Lack of continuous 
funding to maintain 
efforts; leads to 
frequently starting and 
Lack of mental health 
providers in the region to 
serve as a co-located 
providers 
Unsustainable without 
continued funding 
support 
Difficult educating clinic 
staff about referral 
process, charting and 
billing; required frequent 
retraining 
Need to address billing 
and funding issues to 
maintain coordinated 
  
17 
 
 
Limitations 
Preferred the use of a 
mid-level mental health 
provider rather than a 
psychiatrist 
stopping a program 
when funding ends Lack of initial 
infrastructure for 
procedures and 
protocols, including 
consent and 
confidentiality issues 
Scheduling difficulty due 
to limited availability of 
co-located provider  
 
care at same levels 
a
 Information presented in the table reflects comments made by two or more stakeholders 
 
Patient Focus Groups: Two common themes were identified across all patient focus groups: (1) 
communication, and (2) access (Exhibit 8). Communication was a common issue at all of the focus 
groups. The primary issues for patients were a lack of communication between their providers and not 
feeling like their primary care providers truly listened to their health concerns. Several patients 
discussed their frustration that providers did not communicate with each other often enough. Those 
patients made sure they updated their mental health and primary care providers about changes in their 
care or health conditions because the patients felt that, otherwise, their mental health and primary care 
providers would not be aware of issues, such as changes in medication dosages. Several patients also 
discussed problems communicating with their primary care provider about their mental health 
concerns. There was a feeling that their mental health concerns were brushed aside or referred to the 
mental health provider as part of their mental health diagnosis without really listening to the patient’s 
concerns. Some patients did discuss positive communication experiences, primarily with the co-located 
mental health provider. Those patients who had positive communication experiences attributed them to 
the co-located provider who explained treatments, reasons for prescribing medications, and medication 
side effects. 
 
Access to services and resources were also common issues across all sites and focus groups. 
Common access problems mentioned at both pilot sites included access to accurate referral information 
from primary care providers and lack of access to the same primary care or mental health provider over 
time. Several patients expressed frustration at the difficulty of retrieving accurate information about 
community resources and provider information from their primary care provider’s office. The major 
difficulty was that information about resources or referrals was not readily made available unless 
patients explicitly asked for it. When provided with the information, patients’ thought it was extremely 
helpful towards accessing providers and community resources, and important towards improving their 
mental health. Several patients also discussed difficulty in finding providers in their communities willing 
to see Medicaid or uninsured patients. Additionally, patients at the North Central and Southeast sites 
specifically said they had or would go without services if their provider stopped accepting their 
insurance. Several patients also discussed difficulty finding providers with whom they could establish a 
rapport and maintaining those relationships over time. Patients at all of the sites were frustrated that 
facilities in the community had closed or that providers left, which disrupted their access to mental 
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health services. (Note: Patients here were referring to the dislocations that occurred during state-level 
mental health reforms in NC where public mental health agencies were divested of direct care services, 
which were transitioned to networks of private providers. See The News & Observer Mental Disorder:  
The Failure of Reform Series.9) 
 
 
Exhibit 8: Patient Focus Groups: Summary Themes 
 East West North Central Southeast 
Communication 
Providers do not 
communicate with each 
other 
Difficulty communicating 
with primary care 
providers and staff 
Primary care disregards 
symptoms as related to 
mental health conditions 
Primary care could not 
recognize mental health 
conditions 
Providers did not 
communicate with each 
other (improved at 
follow-up) 
Co-located mental health 
provider does a good job 
of explaining treatment 
plan 
Primary care 
overemphasizes use of 
medications without 
explaining reason for 
prescribing or side 
effects 
 
Slow communication 
with parents and patients 
about initial intake, cut 
services, and providers 
leaving 
Past providers did not 
communicate with 
parents or patients about 
symptoms or treatment 
concerns. Current 
providers are better at 
communicating with 
patients and parents 
Access 
Difficult to find providers 
willing to take Medicaid 
and children 
Incorrect information 
about referrals and 
community resources 
Medicaid policies about 
appointment scheduling 
in the same day and 
practice 
Lack of access to 
consistent providers 
Decreasing number of 
providers and services 
supporting the area 
Difficult to create 
consistent relationships 
and rapport with 
providers 
Good access to co-
located mental health 
provider with regular 
appointments 
Lack of mental health 
providers in the 
community. Some 
facilities closed and some 
providers unwilling to 
take Medicaid  
Not enough providers for 
patients in the 
community (in general) 
and not enough 
providers for uninsured. 
Difficulty accessing 
services because of 
transportation issues 
  
Mental Health 
Care 
Improvements 
No positive 
improvements at first 
focus group 
Some positive 
improvements at follow-
up due to patients 
improved navigation of 
the system 
No positive 
improvements or has 
gotten worse between 
first and second focus 
groups due to reduction 
or closing of services in 
community 
Some improvement and 
some have gotten worse. 
Gotten worse due to 
clinician turnover 
Mental health care 
stayed the same – no 
improvement, but care 
has not gotten worse 
Number of 
Participants 
 
Focus Group 1= 7 
Focus Group 2= 9 
 
Focus Group 1= 8 
Focus Group 2= 13 
 
Focus Group 1= 3 
Focus Group 2= 6 
 
Focus Group 1= 3 
Focus Group 2= 4 
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III. Outcome Evaluation 
 
The process evaluation focused on what the pilot sites did during the ICARE demonstration, that is, 
the variety of activities that were undertaken at each pilot to promote primary care and mental health 
services integration.  The results presented in the previous section about these activities indicate that 
both providers and patients believed that services were improved during the ICARE evaluation. The 
questions asked by the outcome evaluation are: “How effective were these activities? Did patients at 
the four pilots experience greater access to quality care during the demonstration?”  To answer these 
questions, data on actual patterns of service use are required to confirm staff perceptions and 
endorsements. 
 
Rationale and Overview 
The common goal for the four ICARE pilots was to serve all target group patients in participating 
practices regardless of payer source. So patients on Medicare, Medicaid, private insurance, as well as 
those paying out-of-pocket were all included. However, from the outset of the ICARE project, the 
Advisory Board recognized that the evaluation budget was inadequate to conduct a prospective study to 
answer these outcome questions for all patients at the four pilots who were exposed to integrated care 
during the ICARE demonstration. Prior to undertaking the evaluation, the Sheps Center was 
commissioned to design a detailed plan for assessing both the processes and outcomes of the ICARE 
pilot sites demonstration. The plan presented to the Foundation laid out the steps we would follow 
including an analysis of Medicaid claims. One advantage of Medicaid claims data is that they were 
already being collected and processed for billing and reimbursements purposes by the Division of 
Medical Assistance, so that no further effort from participating medical practices or time-consuming 
surveys of participating patients would be necessary.  The Board recognized that there was a trade-off 
here between using Medicaid claims data that didn’t require extra data collection costs and not 
capturing the impact of integrated care on all patients who might benefit from these interventions.  
After further consideration, the Board members agreed to endorse the Sheps Center plan including 
Medicaid claims analyses as the only practical way to assess the patient-level impact of the ICARE pilot 
sites demonstration. The Foundation developed a cooperative agreement with the Division of Medical 
Assistance to authorize Sheps Center access to claims data for these purposes. The Division also agreed 
to fund the outcome component of the ICARE pilot sites demonstration.  
 
Medicaid claims data should be interpreted carefully, however; understanding the context around 
which these data are generated is essential to their informed use. In that regard, we note three 
important caveats about Medicaid claims:  
 
1. The claims data reflect only services billed to Medicaid. For grant-funded interventions such 
as ICARE, this means that services paid for by general ICARE funds that were not subject to 
Medicaid reimbursement are not captured in Medicaid claims. If, for example, integrated 
mental health services provided under ICARE were not submitted to Medicaid for 
reimbursement, because clinical staff time was paid for out of study resources, we might 
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observe a decrease in Medicaid mental health expenditures, even though service use may 
have increased.  
 
2. Diagnoses captured in the Medicaid claims data are administrative diagnoses and may 
understate actual clinical diagnoses as recorded in medical charts. Medical providers are well 
known to under-state mental health diagnoses in claims data, therefore the identification of 
individuals through Medicaid claims will undercount the number of individuals with mental 
health disorders.  
 
3. Expenditures in the Medicaid claims file will only reflect expenditures by the state Medicaid 
program and will not include payments from other sources such as Medicare for dually-
enrolled individuals or out-of-pocket payments by consumers. Dually-enrolled Medicaid-
Medicare individuals were included in all analyses reported below to capture the Medicaid 
portion of their expenditures.  
 
Phase 1 of the ICARE pilot sites demonstration began in September 2006 (West) and January 2007 
(East) and ended in June 2008. Phase 2 began at the end of September 2007 (North Central) and 
October 2007 (Southeast) and ended in June 2009. We analyzed Medicaid claims data for January 2005 
through June 2008 providing a 12 month period prior to the start of the ICARE demonstration to 
establish a baseline and up to 12 months afterwards to assess the impact of the two-year demonstration 
on a variety of types of health service use and Medicaid expenditures. Follow-uptimes varied for the 
four pilots due to the six to twelve-month time lag between the date a claim is filed with Medicaid and 
the date that claims are reconciled and paid. The latest paid claims data we were able to access was 
through June 2008. To facilitate comparisons among pilots, we wanted the length of the follow-up 
period to be similar for each ICARE phase. So we ended up using a 12 month follow-up for the Phase 1 
pilots (East and West) and 9-to-10 months for the Phase 2 pilots (North Central and Southeast).  
 
We included a comparison or control group to infer whether any change in health care use and 
expenditures can be plausibly attributed to the ICARE integrated care intervention rather than other 
secular trends occurring at the same time. Random assignment to intervention and control groups was 
not employed. Rather, we used a quasi-experimental design with pre-post comparisons between 
intervention patients and similar groups of control patients. We report results from the following five 
types of health service expenditures from the NC Medicaid claims data on a quarterly basis for each 
patient: 
1. Outpatient mental health expenditures  
2. All outpatient expenditures (medical and mental health combined) 
3. Emergency department expenditures  
4. Psychotropic drug prescription expenditures 
5. Total Medicaid expenditures on all service categories 
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Methods 
1. Treatment and Control Groups 
At each site, we identified two groups of Medicaid-enrolled individuals who may have benefited 
from the ICARE pilot sites intervention. First, we obtained a list of Medicaid enrollees who were 
reported by the pilots as directly receiving intervention services. This group of individuals is considered 
to have been directly exposed to the ICARE integrated care intervention by virtue of having been 
identified by the ICARE staff at each pilot site. Second, we also identified from the claims data all other 
individuals with the target diagnoses who received services from each ICARE pilot during the one-year 
period prior to ICARE. This later group may not have received targeted services from integrated care 
providers per se, but may have benefited at a practice-level from increased training and interactions 
between medical and specialty mental health providers. We provide more details on these two groups 
and the control groups below. Separate analyses were conducted for each ICARE pilot because of the 
differences in target populations (Exhibit 8). Detailed tables presenting baseline measures and effects of 
the interventions are presented in Appendices A-C; summary highlights are presented and discussed in 
the results section below.  
 
Group One: The primary intervention group is comprised of patients in each practice who were 
directly exposed to the ICARE treatment. In anticipation of this analysis, we requested site coordinators 
to provide Medicaid ID numbers for all patients who received a service from the ICARE behavioral health 
provider. Subsequently, the Division of Medical Assistance matched these numbers with the encrypted 
identification numbers in the Medicaid data extracts made available to the Sheps Center. In this way, we 
were able to identify ICARE patients in the claims data without having access to unencrypted identifiers.  
 
 
Exhibit 8: Pilot Site Target Diagnoses 
Phase 1 Phase 2 
East West North Central Southeast 
All individuals with a 
mental health and/or 
substance abuse diagnosis 
Bipolar, schizophrenia, 
schizoaffective disorder, 
depressive psychosis, or 
psychosis not otherwise 
specified in addition to a 
diabetes, asthma, COPD, or 
congestive heart failure 
diagnosis 
Adults: Postpartum depression, 
other depressive disorders, sexual 
dysfunction disorders, and anxiety 
disorders (some individuals had a 
co-occurring substance abuse or an 
additional mental health diagnosis) 
Children: attention-
deficit/hyperactivity disorder, 
depression, adjustment disorders, 
oppositional-defiant disorders, 
anxiety disorders, obsessive-
compulsive disorder, autism, or 
Aspergers 
All individuals with a 
mental health and/or 
substance abuse diagnosis 
 
Although in theory intervention effects would be most observable for this group of patients who 
were directly exposed to the integrated care interventions, it is questionable whether the effect will be 
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precisely observed due to the small sample size of this group. Further, we are unable to validate the 
completeness of these lists. Site coordinators had difficulties in responding to our requests for lists of 
patients exposed to integrated care and we encountered repeated delays in obtaining them. We 
interpret these difficulties as evidence that the demonstration was not viewed by participating practices 
as an intervention for which patients were enrolled the way they would have been in a clinical trial, i.e., 
a clear distinction made between enrolled and not-enrolled patients that affected what services they 
received. Consequently, we believe that Group Two (see below) effects are more reliable indicators of 
the patient-level impact of the ICARE interventions. However, for the interested reader, we include 
Group One results as well in Appendices A-C. 
 
Group Two: A secondary intervention group was defined as all patients in the same practices during 
the study period who received one or more target diagnoses (Exhibit 8) during the one-year pre-ICARE 
period but whose identification numbers were not specifically reported by site managers in Group One. 
Analysis of this group allows us to detect diffusion or “spill-over effects” and it potentially captures 
effects among directly exposed individuals if the Group One lists were incomplete. If present, these 
spillover effects would suggest that a change in practice occurred during the ICARE intervention such 
that providers generalized their intervention approach to similar patients treated during the ICARE 
demonstration period. These analyses were conducted without any major burden on practice personnel, 
but they did require a set of billing codes for all providers at each ICARE pilot site in order to identify the 
patients they treated.  
 
Control Group: The comparison patients or control group was drawn from all individuals in NC 
Medicaid who received diagnoses similar to the intervention group at each pilot site, but did not see an 
ICARE provider during the full study period. The control groups were constructed separately for each 
pilot. This process again relies on the use of ICARE provider billing codes; but unlike the construction of 
Group Two, the billing codes were used as an exclusion criterion rather than an inclusion criterion. 
Patients in Groups One and Two for any of the four pilots were excluded as controls from the NC 
Medicaid files for these analyses. We did not need to contact non-ICARE sites for this information.  
 
The adequacy of these comparison groups was established by examining trends in outcome variables 
in the one year pre-ICARE study period. We examined quarterly indicators on levels of use and trends in 
use during the baseline period and selected control patients based on similar trends in outcomes.  It 
should be noted that there are some differences in the pre-period between the control and treatment 
groups for the Western and North Central sites (see Appendix A). 
 
2.  Analytic Methods 
The Medicaid data were collapsed to the person-quarter level. This means that each patient’s 
service use was summed over consecutive three-month periods throughout the study interval, based on 
the implementation date of each ICARE pilot, and that the analyses were then performed on these 
quarterly observations. For this analysis, the data span up to eight quarters (four pre-intervention, four 
post-intervention) for Phase 1 pilots and 7+ quarters for Phase 2 pilot (four pre-intervention, and 3+ 
post-intervention). We controlled for linear time tends in individual treatment that occurred statewide.  
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A two-part regression model with individual level fixed effects was used for this analysis. The two-
part modeling approach allows us to determine whether ICARE had an effect on access to care (part 
one), and separately, on the level (amount) of service use (part 2) among those who did access services.  
 
We controlled for individual fixed effects or time invariant characteristics of patients, their 
providers, practices, and communities that may affect both the propensity to use services and those 
characteristics that may confound results of the integrated care demonstration, such as provider-
specific effects. Some examples of individual time invariant characteristics that affect health care 
utilization might be gender, race, health status, propensity to use care, and locational characteristics 
that are constant over the 9 – 12 month period examined here. The fixed effects analysis allows us to 
control for differences that exist among individuals but are unobserved by the evaluator. For instance, 
an individual may have a history of mental illness within his family and thus be more likely to use mental 
health services but this would not be recorded in claims data. A fixed effects analysis offers a means of 
controlling for the invariant differences among individuals, such as family history of mental illness. The 
standard errors are adjusted for clustering, or repeated observations, at the individual level. 
 
The two-part regression model helps us analyze the effect of the ICARE intervention by assessing 
the likelihood of use of mental health services as well as the level or intensity of health care utilization 
among users as measured by Medicaid reimbursement. We ran five two-part models for each site, 
examining the impact of ICARE on the likelihood of any use and the level of expenditures for (1) 
outpatient mental health, (2) all outpatient, (3) emergency department, (4) psychotropic drug, and (5) 
total expenditures. The magnitude of the coefficients (difference-in-difference estimates), reported in 
Appendix Table C, describes the difference in outcome for those who received ICARE services over the 
level expected in the absence of ICARE, based on trends in the control group and in the pre-ICARE 
period. 
 
Results 
Detailed tables presenting baseline and outcome data for each of the four pilots are presented in 
Appendices A-C. Here, we will highlight the main findings for Group Two separately for each pilot as 
displayed in Exhibit 9. This is a schematic summary of the findings presented in the detailed tables in the 
Appendices. Notations with plus (+) signs indicate that patients in ICARE pilot sites were significantly 
more likely to access care or had greater expenditures, on average, than Control patients; those with 
minus (-) signs indicate that patients in ICARE pilots were significantly less likely to access care or had 
lesser expenditures, on average, than Control patients. Double signs indicate the .01 significance level 
whereas a single sign indicates the .05 significance level. Empty cells indicate no effects of integrated 
care or potential budget neutrality; that is, for these cells, patients in ICARE pilot sites are predicted to 
not cost Medicaid any more or less than Control patients. 
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Exhibit 9: Summary Regression Results for Effects of ICARE Integrated Care Demonstration on Selected 
Medicaid Expenditures Per Quarter for Group Two Participants 
Expenditures Likelihood of Use Amount of Use 
 Phase 1 Pilots Phase 2 Pilots Phase 1 Pilots Phase 2 Pilots 
 East West NC SE East West NC SE 
Outpatient 
Mental Health 
-- 
-6.8% 
- 
-4.2% 
++ 
12.4% 
++ 
6.3% 
++ 
$344 
  ++ 
$1341 
Total 
Outpatient 
-- 
-11.0% 
 ++ 
8.8% 
  
 
-- 
-$374 
++ 
$353 
++ 
$1087 
Emergency 
Department 
 - 
-2.9% 
 ++ 
6.4% 
+ 
$130 
   
Psychotropic 
Medications 
++ 
1.0% 
 ++ 
3.6% 
  ++ 
$56 
  
Total Medicaid -- 
-4.1% 
 ++ 
8.5% 
 - 
-$82 
 ++ 
$258 
++ 
$1076 
 
Overall, small but statistically significant percentage and dollar differences were observed in 55% 
(22 of 40) of the comparisons between Group Two and Control patients. The 45% of comparisons with 
no significant differences indicate situations where ICARE patients were, on average, no more or less 
likely to incur expenditures or have different amounts of expenditures than were Control patients. 
Below, we will review these patterns of results separately for each type of expenditure. 
 
The results for Outpatient Mental Health Expenditures have the most direct implications for the 
patterns of care resulting from the demonstration. We see in the left side of Exhibit 9 (likelihood of use) 
that the Group Two ICARE patients at the Phase 2 pilot sites (NC and SE) were significantly more likely to 
access services (6% and 12%) and have greater expenditures ($353 and $1,087), on average, than did 
Control patients. However, in the Phase 1 pilots (East and West), ICARE patients Group 2 were 
significantly less likely to access Medicaid-funded outpatient mental health services (-4% and -6.8%), on 
average, than did Control patients.  
 
As described in the introduction to this section, the Phase 1 (East and West) results could have 
occurred if ICARE grant funds substituted for Medicaid-paid services and thus the likelihood of using a 
mental health service captured in the Medicaid claims data decreased. This could have occurred if 
services provided by the co-located providers reduced the need for target patients to use outside 
mental health services. However, if sites were billing Medicaid for all mental health services by the co-
located provider, then this finding would indicate a real decrease in the access to mental health care in 
an average quarter.  The difference between Phase 1 and Phase 2 sites might also be due to shared 
learning among pilots. The ICARE demonstration operated as a learning community throughout the 
demonstration with regular meetings among pilot site staff and varieties of both on-site and off-site 
technical assistance. Shared learning might have allowed the Phase 2 sites to accelerate implementation 
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and Medicaid billings for mental health services. If so, this would help to explain the increases in 
Medicaid billable mental health service use at Phase 2 (NC and SE) pilots.  
 
In terms of outpatient mental health expenditures by service users, we see in the right side of 
Exhibit 9 (amount of use) that the level of service use increased significantly in two sites (East and SE) 
and reminded constant in the other two sites (West and NC). It is difficult to know how to interpret 
these last findings without knowing more about the patients’ level of functioning, information that is not 
available in Medicaid claims. Interestingly, the West pilot, which experienced a decline in the rate of 
accessing services each quarter and no difference in the level of expenditures among those that did use 
services, targeted patients with serious mental illness and medical comorbidities. Perhaps integrated 
primary care in this situation can lead to reduced use of outpatient mental health services at agencies 
outside the medical practice. The East and Southeast both targeted adults and children/youth with a 
broad focus on all mental disorders.  Here, information on level of functioning would also help to 
interpret these average increases.   
 
Total Outpatient Expenditures is a composite of all mental health and medical care services. Here, 
the East pilot experienced decreases in the likelihood of outpatient use and the North Central site 
experienced increases; the remaining two sites were budget neutral (no significant differences) on the 
amount of expenditures between ICARE patients and Controls. ICARE patients at the Southeast 
($1,087/quarter) and NC ($353/quarter) pilots had significantly greater total outpatient Medicaid 
expenditures, on average, than did Control patients among those who used services. ICARE patients in 
the West pilot, however, had lower overall outpatient expenditures (-$374/quarter) among those that 
used outpatient services. 
 
With regard to Emergency Department (ED) Expenditures, ICARE patients at the Southeast pilot had 
an increased likelihood of ED use relative to Control patients, while patients at the West pilot had a 
decreased likelihood of use. On the amount of expenditures side, only ICARE patients at the East pilot 
showed an increase ($130/quarter) in per patient ED expenditures for ED users in comparison to Control 
patients. For Psychotropic Medication Expenditures, the East and North Central pilots showed small 
increases in the likelihood of having any psychotropic medication claim without a corresponding 
increase in the amount of expenditures for psychotropic medications. Only the West pilot ($56/quarter, 
on average) revealed a significant difference in the amount of expenditures for psychotropic 
medications by ICARE patients relative to Controls.  
 
Finally, regarding Total Medicaid Expenditures, the overall effect was very different across sites. 
ICARE patients at the North Central pilot had a greater likelihood of using Medicaid services than did 
Control patients and a greater level of expenditures among those who did use services ($258/quarter). 
This means that Medicaid expenditures in the NC pilot were clearly greater for ICARE participants. In 
contrast, ICARE patients at the East pilot had a lesser likelihood of using Medicaid services and lesser 
expenditures among those who used services, indicating a net decrease in Medicaid expenditures. ICARE 
patients at the Southeast pilot were no more or less likely to use services in each quarter, but those who 
did had greater expenditures ($1,076/quarter). Finally, we observed no difference in the level of total 
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expenditures for patients at the West site.  Also, it should be noted that the lower access to outpatient 
mental health services at Phase 1 pilots translates to cost savings for one of those pilots (East) and that 
increased access as observed for the two Phase 2 pilots translates to greater costs for both of these 
sites. 
 
  
27 
IV. Discussion 
 
There is a consistency in the findings between the process and outcome components of the ICARE 
integrated care evaluation but it takes several steps to describe and explain it. Process-wise, we found 
that there was widespread support and buy-in for integrated care activities among the participating 
primary care practices. Stakeholders at all four pilot sites agreed that the ICARE demonstration was a 
beneficial program that created new connections between mental health and primary care, increased 
communication and created contacts that did not exist prior to the ICARE demonstration. Practice staff 
was eager to make changes in practice routines to increase the integration of primary care and mental 
health services. Each pilot made demonstrable progress in bringing the two services closer together in a 
more coordinated way through co-located behavioral health providers and other supports. Remarkably, 
these endorsements were similar across a variety of primary care practices in diverse areas of North 
Carolina that targeted a different mental health conditions ranging from severe mental illness to anxiety 
and substance use across different age groups. 
 
Outcome-wise, the Medicaid claims results were more varied across the four pilots. The Phase 1 
pilots (East and West) showed small but significant decreases (3% - 11%) in Medicaid-reimbursed 
outpatient and ED service use.  Whereas the Phase 2 pilots (North Central and Southeast showed small 
but significant increases (4% - 12%) in Medicaid outpatient and ED service use. We suggested that these 
differences might be associated with the role of co-located mental health providers and with shared 
learning among pilots which accelerated implementation and billings at Phase 2 pilots. (Recall that the 
two phases of ICARE demonstration overlapped one year; the 02 year for Phase 1 was the 01 year of 
Phase 2). We also noted that, for the most part, the increased access for patients in the start-up period 
at ICARE Phase 2 pilots was associated with increased quarterly per patient Medicaid costs.  
 
Missing in the above interpretations of the ICARE pilot evaluation results are data on the same day 
Medicaid billing for primary care physicians and co-located mental health providers. When the Phase 1 
pilots were first created, NC Medicaid had prohibitions against same day billing, but the Division of 
Medical Assistance did authorize same day billing during Phase 2 of the demonstration.  Tracking the 
billing behavior of individual clinicians within participating primary care practices and their co-located 
providers over time would have helped to determine whether the interpretations suggested above are 
correct. However, such an effort fell outside the workscope of the present evaluation. This would be an 
important issue to examine in future efforts to expand integrated care throughout the state of North 
Carolina. 
 
A longer-term follow-up assessment would help to clarify these findings. We had to limit the 
outcomes assessment in this evaluation to a 9 – 12 month follow-up due to both the lag times 
associated with obtaining reconciled and cleaned Medicaid paid claims files and the timeline specified in 
our agreements with the Foundation and the Division of Medical Assistance. Having data on the full 24 
month experience of Phase 1 and Phase 2 pilots would be particularly informative about whether there 
was a tipping point in the second year where increased mental health access led to reductions in 
Medicaid expenditures for ICARE patients relative to control patients. This information is preserved in 
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the Medicaid claims files data so both these trends as well as the billings of participating primary care 
physicians, co-located providers, and out-of-practice mental health clinicians can be reconstructed. 
These historical files would allow for an even longer term 3-4 year follow-up to assess whether there 
was a continuing benefit for ICARE patients who were exposed to the integrated care interventions. 
 
On-going funding is consistently the major barrier to sustainability of any integration effort that has 
been reported in the literature3, and this was a barrier for each of the ICARE pilot sites as well. Among 
the challenges during ICARE, determining how to bill for mental health services provided in the primary 
care setting was a significant challenge. ICARE central staff and technical consultants held regular 
trainings for primary care office staff on billing for mental health services, but practices still struggled 
with the process. As ICARE neared its end, sites also struggled with how to continue without grant 
funding support. Under current reimbursement policies, the viability of integrated care turns on the 
proportion of patients in a medical practice who are Medicaid eligible. The greater the number of 
Medicaid patients in a practice with mental disorders, the greater the reimbursement opportunities and 
therefore the more sustainable integrated care becomes. This funding mechanism is much more viable 
for pediatric practices than for general family medicine practices because of the preponderance of 
youngsters in pediatric practices who are Medicaid eligible.  Sustainability is much less certain in adult-
based practices where the preponderance of patients are typically covered by various proportions of 
Medicare, private insurance, and self-pay arrangements with a only small proportion on Medicaid. 
 
As a result, with the schedule termination of the ICARE pilots, some of the sites had to end their 
integration efforts all together while others transferred ICARE activities and patients into other local 
care management programs such as the co-location grants sponsored by Community Care of North 
Carolina (CCNC), the networks of primary care practices organized under the state Medicaid program. 
Stakeholders agreed that until these barriers were removed and a stable funding source could be 
identified, it would be difficult to maintain integrated care at their location. The clear implication is that 
if sustainable improvements in integrating mental health in primary care settings are to occur in North 
Carolina, then innovations have got to occur at the health care financing level as well as at the medical 
practice-level. Figuring out how to pay for integrated care is a major unsolved problem in North Carolina 
and nationally that will continue to constrain and undermine innovative practices for patients needing 
these services. 
 
The juxtaposition of these process and outcome results raises important policy implications. The 
ICARE pilot sites demonstration did promote greater access to Medicaid-reimbursed services for many 
patients with mental health problems who have had access barriers and obstacles to overcome in the 
past. Yet, this relatively short-term evaluation (only 9 - 12 months of follow-up data) relying exclusively 
on Medicaid claims data, was unable to show functional improvements or substantial cost savings for 
targeted patients at ICARE pilot sites. Nationally, it has proven very difficult even with larger studies and 
longer-term follow-ups to show any consistent medical cost-offsets (savings) from providing enhanced 
mental health services to patients in primary care settings. Our findings here are consistent with 
research conducted elsewhere. They also raise the policy issue that is faced by states around the 
country, viz., in these difficult economic times do Medicaid programs continue to make investments like 
  
29 
ICARE in the increased access and use of mental health services by patients in primary care settings even 
without evidence of overall  cost savings?  Obviously, this is a much bigger issue than we can adequately 
address with the limited findings from the ICARE pilot sites evaluation. 
 
What are the implications of the ICARE pilot demonstration experience in going forward with 
further efforts in North Carolina to integrate mental health and primary care? Here, we would like to 
flag an issue that we noted very early in our evaluation efforts. Namely, there may well have been a 
trade-off in the design and impact of the ICARE demonstration as implemented over the past few years. 
The generally enthusiastic buy-in from practice staff might have been largely facilitated by the decision 
to let each pilot design their own intervention rather than follow a fixed, intensive protocol. However, 
such an open-ended, decentralized approach may have limited the strength and impact of the 
interventions as well.  Future efforts to establish a business case for the integration of primary care and 
mental health services care would benefit from more consistent, focused, and robust interventions that 
can be shown to lead to improvements in health status and more efficient (i.e., less costly) use of 
Medicaid and other health insurance programs. Having such an evidence-base would make the 
prospects for integrated care much brighter in North Carolina and elsewhere around the country.  
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Appendix A. Descriptive statistics for Medicaid expenditures one year prior to ICARE implementation 
at each site for Intervention Groups 1 and 2 and Controls 
Variable Proportion with Use (%) Level of use by service users ($) 
 East West NC SE East West NC SE 
Outpatient Mental Health Expenditures 
Group 1 a  79.41 89.80 -- d 58.02 696.60 2,607.22 -- d 6,621.71 
Group 2 b  59.68 91.78 70.77 57.45 6,988.52 6,328.74 7,712.59 10,402.10 
Controls c 48.74 56.20 68.92 52.35 4,308.37 2,611.62 4,985.17 5,320.81 
Outpatient Expenditures 
Group 1  97.06 91.84 100 100 1,927.20 4,391.18 2,763.09 6,289.30 
Group 2  98.85 97.60 98.65 99.24 5,955.38 9,822.09 8,509.98 8,615.65 
Controls 95.55 57.49 71.33 97.06 4,327.88 4,930.45 6,405.41 5,430.27 
Emergency Department Expenditures 
Group 1  17.65 57.14 -- d 38.93 311.30 790.99 -- d 722.23 
Group 2  13.07 68.15 57.71 31.86 465.18 1,379.72 832.82 493.79 
Controls 38.84 29.14 27.30 38.79 668.23 913.05 850.23 678.53 
Psychotropic Drug Expenditures 
Group 1  47.06 36.73 -- d 24.43 572.83 1,088.59 -- d 420.11 
Group 2  20.67 75.68 42.90 17.03 949.06 951.13 656.16 735.36 
Controls 27.08 38.49 29.35 21.95 683.80 680.81 722.12 766.66 
Total Expenditures 
Group 1  97.06 91.84 100 100 4,123.85 9,044.42 3,763.03 7,779.14 
Group 2  98.89 98.29 98.86 99.24 7,076.71 16,280.68 10,712.43 9,956.15 
Controls 97.42 57.60 71.47 97.71 6,221.71 8,842.50 8,405.31 7,233.02 
a Group 1 consists of individuals specifically identified by the study sites as receiving the intervention. 
The sample size of this group is as follows: N=34 (East); N=131 (SE); N=49 (West); N=7 (NC). 
b Group 2 consists of individuals who received treatment at an ICARE practice affiliated with the site and 
who matched the outlined targeted diagnoses. The sample size of this group is as follows: N= 3,053 
(East); N=4,080 (SE); N=292 (West); N=1,485 (NC) 
c Controls consist of Medicaid beneficiaries in North Carolina who did not receive treatment at any 
ICARE practice but who matched the targeted diagnoses outlined by the site. The sample size of this 
group is as follows: N= 307,259 (East); N=313,296 (SE); N=29,591 (West); N=186,859 (NC) 
d Sample size was too small to conduct a comparison 
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Appendix B. Descriptive Statistics for Medicaid Expenditures One Year After ICARE Integrated Care 
Implementation 
Variable Proportion with Use (%) Level of use by service users ($/visits) 
 East West NC SE East West NC SE 
Outpatient Mental Health Expenditure 
Group 1 a 90.70 95.92 85.71 73.57 4,532.21 4,613.89 1,064.53 14,986.66 
Group 2 b 62.40 94.79 72.02 64.27 9,816.20 7,451.92 7,533.61 16,574.41 
Controls c 52.75 60.82 64.32 52.72 6,755.07 3,791.49 3,900.23 6,647.07 
Total Outpatient Expenditures 
Group 1 100.00 100.00 100.00 100.00 6,324.07 7,001.31 1,409.52 13,741.56 
Group 2 98.82 98.96 97.66 99.07 7,635.85 11,151.80 8,693.06 13,494.19 
Controls 97.54 62.12 66.91 97.49 6,294.83 6,245.66 5,000.46 6,223.51 
Emergency Department Expenditures 
Group 1 30.32 59.18 -- d 43.57 564.54 958.50 -- d 994.13 
Group 2 14.07 68.06 56.08 42.68 655.63 1,452.14 859.19 616.80 
Controls 39.41 32.43 25.08 38.94 709.49 995.50 887.35 709.74 
Psychotropic Drug Expenditures 
Group 1 65.12 46.94 -- d 27.86 840.13 1,117.00 -- d 603.07 
Group 2 19.81 71.88 42.75 18.00 959.38 1,368.21 682.69 726.65 
Controls 21.59 36.11 27.22 21.48 787.05 759.29 644.83 783.87 
Total Expenditures 
Group 1 100.00 100.00 100.00 100.00 9,894.19 13,176.40 3,417.39 15,761.02 
Group 2 98.85 98.96 97.94 99.17 8,818.91 18,425.11 10,920.19 14,965.01 
Controls 98.16 62.27 67.29 98.00 8,144.16 9,974.24 6,841.24 8,082.92 
a Group 1 consists of individuals specifically identified by the study sites as receiving the intervention. 
The sample size of this group is as follows: N= 43 (East); N=140 (SE); N=49 (West); N=7 (NC). 
b Group 2 consists of individuals who received treatment at an ICARE practice affiliated with the site and 
who matched the outlined targeted diagnoses. The sample size of this group is as follows: N= 3,226 
(East); N=4,201 (SE); N=288 (West); N= 1,455 (NC) 
c Controls consist of individuals who did not receive treatment at any ICARE practice but who matched 
the targeted diagnoses outlined by the site. The sample size of this group is as follows: N=325,033 (East); 
N=331,668 (SE); N=30,142 (West); N=180,827 (NC) 
d -- Sample size was too small to conduct a comparison 
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Appendix C. Regression Results for ICARE Integrated Care Outcomes 
Variable Differential likelihood of use+ Differential amount conditional on any use 
 East West NC SE East West NC SE 
Outpatient Mental Health Expenditures 
Group 1 0.104* 
(0.045) 
0.219**   
(0.041) 
0.104  
(0.118) 
0.148**  
(0.022) 
499.421  
(503.650) 
-418.614   
(323.701) 
-948.859   
(1640.632) 
3199.289** 
(330.893) 
Group 2  -0.068** 
(0.005) 
-0.042*   
(0.017) 
0.124** 
(0.008) 
0.063**   
(0.004) 
343.765**   
(73.015) 
-196.923   
(131.576) 
95.943  
(99.797) 
1340.689**   
(62.181) 
Total Outpatient Expenditures 
Group 1  0.122**   
(0.037) 
0.278**   
(0.041) 
0.053   
(0.113) 
0.028*   
(0.013) 
546.878   
(329.862) 
-555.700   
(360.168) 
78.405   
(937.917) 
1852.575**   
(154.135) 
Group 2 -0.110**   
(0.004) 
-0.023   
(0.018) 
0.088**   
(0.008) 
0.002   
(0.002) 
2.455   
(33.650) 
-374.436**   
(140.735) 
352.975**    
(70.782) 
1086.666**   
(28.152) 
Emergency Department Expenditures 
Group 1 0.071    
(0.042) 
0.090** 
(0.031) 
0.037   
(0.076) 
0.058**  
(0.022) 
118.757    
(312.747) 
-65.964   
(207.483) 
211.624    
(1498.960) 
20.645   
(120.643) 
Group 2  -0.001   
(0.005) 
-0.029* 
(0.013) 
0.001    
(0.005) 
0.064**   
(0.004) 
130.118*    
(63.114) 
86.488   
(83.429) 
-33.277   
(47.786) 
6.692    
(30.425) 
Psychotropic Drug Expenditures 
Group 1 0.118**   
(0.030) 
0.117** 
(0.033) 
0.033  
(0.076) 
0.051**    
(0.015) 
116.464*  
(60.664) 
-108.692   
(66.100) 
-130.887    
(230.304) 
5.233   
(50.354) 
Group 2 0.010**   
(0.003) 
0.017   
(0.014) 
0.036**   
(0.006) 
0.005   
(0.003) 
-12.066   
(11.241) 
55.897**   
(20.583) 
-10.155   
(13.132) 
-8.502   
(11.195) 
Total Expenditures 
Group 1 0.198**   
(0.029) 
0.278** 
(0.041) 
0.051   
(0.113) 
0.020   
(0.011) 
671.486   
(377.238) 
-577.577   
(397.252) 
254.188   
(973.742) 
1942.013**   
(173.910) 
Group 2 -0.041**   
(0.003) 
-0.025   
(0.018) 
0.085**    
(0.008) 
0.002    
(0.002) 
-82.186*  
(38.306) 
-179.543   
(154.376) 
257.589** 
(72.980) 
1075.639**   
(31.757) 
Notes: 
+ Values represent differential effects over the control group, i.e., differences in how likely service 
use or expenditures occurred. For instance, the upper most cell in the first column can be interpreted as 
follows, “Being in group one in the Eastern site increases an individual’s likelihood of having any 
outpatient mental health expenditure by 10.4 percentage points relative to individuals in the control 
group.”  
Standard errors are reported in parentheses 
* Indicates that coefficient is significant at the 5% level  
** Indicates that coefficient is significant at the 1% level 
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Appendix D. Dimension of Integration Survey Tool 
I.  TREATMENT PATTERNS  
For those 
patients whom 
you believe to 
have a clinically 
relevant 
psychiatric 
diagnosis of 
______________
_ 
What percentage 
to you 
0-20% 
 
1 
21-40% 
 
2 
41-60% 
 
3 
61-80% 
 
4 
81-100% 
 
5 
TP1 
Watchfully wait 
without 
intervening? 
1 2 3 4 5 
Manage 
yourself? 1 2 3 4 5 
Refer for help to 
a co-located 
provider? 
1 2 3 4 5 
Refer for help to 
a specialty 
mental health 
provider located 
outside of your 
office? 
1 2 3 4 5 
II.  CLINICAL ALGORITHMS/BEST PRACTICES 
When a patient 
presents with 
symptoms, 
physicians in 
our practice use 
a published, 
evidence-based 
diagnostic tool 
for: 
0-20% of the time 21-40% of the time 
41-60% of the 
time 
61-80% of the 
time 
81-100% of the 
time 
CA1  
Depression 1 2 3 4 5 
CA2 
Anxiety 1 2 3 4 5 
CA3  
ADHD/ADD 1 2 3 4 5 
CA74 
Bipolar Disorder 1 2 3 4 5 
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CA5 
Substance Abuse 1 2 3 4 5 
III. CRISIS ASSESSMENT SERVICES 
CAS1  
What is your 
practice level of 
knowledge 
about the 
availability of 
community-
based crisis 
assessment 
services? 
There are no 
crisis 
assessment 
services 
available in our 
community 
 
 
0 
Know nothing 
about the 
availability of 
community-
based crisis 
assessment 
services 
 
1 
Know very little 
about the 
availability of 
community-
based crisis 
assessment 
services 
 
2 
Know 
something 
about the 
availability of  
community-
based crisis 
assessment 
services 
 
3 
Know a good 
bit about the 
availability of 
community-
based crisis 
assessment 
services 
 
4 
Know all about 
the availability 
of community-
based crisis 
assessment 
services 
 
 
5 
CAS2 
What is your 
practice level of 
knowledge 
about how to 
access 
available 
community-
based crisis 
assessment 
services? 
There are no 
crisis 
assessment 
services 
available in our 
community 
 
 
 
0 
Know nothing 
about how to 
access 
available 
community-
based crisis 
assessment 
services 
 
 
1 
Know very little 
about how to 
access 
available 
community-
based crisis 
assessment 
services 
 
 
2 
Know 
something 
about how to 
access 
available 
community-
based crisis 
assessment 
services 
 
 
3 
Know a good 
bit about how 
to access 
available 
community-
based crisis 
assessment 
services 
 
 
4 
Know all about 
how to access 
available 
community-
based crisis 
assessment 
services 
 
 
5 
CAS3  
Does your 
practice refer 
patients to 
available 
community-
based crisis 
assessment 
services when 
needed? 
There are no 
crisis 
assessment 
services 
available in our 
community 
 
 
 
 
0 
Never Refer  
 
 
 
 
 
 
 
 
1 
Rarely Refer 
 
 
 
 
 
 
 
 
2 
Sometimes 
Refer 
 
 
 
 
 
 
 
3 
Usually Refer 
 
 
 
 
 
 
 
 
4 
Always Refer 
 
 
 
 
 
 
 
 
5 
CAS4 
When you refer 
a patient to 
community-
based crisis 
assessment 
services, how 
often do you 
know if 
services are 
received? 
There are no 
crisis 
assessment 
services 
available in our 
community 
 
 
 
 
0 
0-20% of the 
time 
 
 
 
 
 
 
 
1 
21-40% of the 
time 
 
 
 
 
 
 
2 
41-60% of the 
time 
 
 
 
 
 
 
3 
61-80% of the 
time 
 
 
 
 
 
 
4 
81-100% of the 
time 
 
 
 
 
 
 
5 
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CAS5 
Based on the 
information that 
you receive, how 
often do you think 
your patients 
actually receive 
community-based 
crisis assessment 
services when 
referred? 
Never receive 
services when 
referred 
 
 
 
 
 
 
 
1 
Rarely receive 
services when 
referred 
 
 
 
 
 
 
 
2 
Sometimes 
receive services 
when referred 
 
 
 
 
 
 
 
3 
Usually receive 
services when 
referred 
 
 
 
 
 
 
 
4 
Always receive 
services when 
referred 
 
 
 
 
 
 
 
5 
IV. PHYSICAL PROXIMITY 
PP1 
How closely 
located are the 
available 
specialty mental 
health 
services/LME and 
your primary care 
office? 
In different 
town/city 
 
 
 
 
 
1 
Across City/Town 
 
 
 
 
 
2 
Same side of 
city/town (3-15 
blocks) 
 
 
 
3 
Within 1-2 blocks 
 
 
 
 
 
4 
Same office or 
building 
 
 
 
 
5 
PP2 
What space is 
available in your 
primary care 
office to support 
co-located mental 
health? 
There is no space 
available for 
mental health 
treatment in the 
primary care office 
 
1 
There is shared 
space available 
for mental health 
treatment, but it is 
inadequate 
 
2 
There is dedicated 
space available 
for mental health 
treatment, but it is 
inadequate 
 
3 
There is adequate 
space for 
integrated mental 
health treatment 
that is also used 
for other purposes 
4 
There is adequate 
space dedicated 
to integrated 
mental health 
treatment 
 
 
5 
V.  TEMPORAL PROXIMITY 
TP1 
What is the 
typical 
amount of 
time between 
PCP referral 
and a 
patient’s first 
mental health 
visit with a 
co-located 
mental health 
provider 
located 
inside the 
primary care 
practice? 
There is 
no co-
located 
provider 
in the 
primary 
care 
practice 
 
 
1 
Greater 
than 3 
months 
 
 
 
 
 
 
 
 
2 
1-3 months 
 
 
 
 
 
 
 
 
 
3 
2-4 weeks 
 
 
 
 
 
 
 
 
 
4 
1-2 weeks 
 
 
 
 
 
 
 
 
 
5 
2-6 days 
 
 
 
 
 
 
 
 
 
6 
1 day 
 
 
 
 
 
 
 
 
 
7 
Same Day 
 
 
 
 
 
 
 
 
 
8 
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TP2 
What is the 
typical 
amount of 
time 
between a 
PCP referral 
and a 
patient’s first 
specialty 
mental 
health/LME 
visit outside 
of the 
primary care 
practice? 
Greater than 
3 months 
 
 
 
 
 
 
 
 
 
1 
1- 3 months 
 
 
 
 
 
 
 
 
 
 
2 
2-4 weeks 
 
 
 
 
 
 
 
 
 
 
3 
 
1-2 weeks 
 
 
 
 
 
 
 
 
 
 
4 
2-6 days 
 
 
 
 
 
 
 
 
 
 
5 
1 day 
 
 
 
 
 
 
 
 
 
 
6 
Same Day 
 
 
 
 
 
 
 
 
 
 
7 
VI.  COMMUNICATION 
The next seven questions pertain to communication with the co-located provider in your practice 
C1 
What 
information is 
typically shared 
with the co-
located mental 
health provider 
by the referring 
PCP prior to a 
patient’s first 
co-located 
mental health 
visit? 
There is no co-
located 
provider in the 
primary care 
practice 
 
 
 
 
 
0 
 
 
 
There is no 
information 
shared prior to 
the first visit 
 
 
 
 
 
1 
A referral is 
made but no 
patient 
information is 
shared other 
than name 
 
 
 
2 
A referral is 
made and 
some patient 
information is 
shared 
 
 
 
 
3 
A referral is 
made and 
portions of 
medical chart 
are shared 
 
 
 
 
4 
A referral is 
made and full 
medical chart 
is shared 
 
 
 
 
 
5 
C2 
How often does 
the referring 
PCP initiate 
written 
communication 
(referral letter 
or email) with 
the co-located 
mental health 
provider and 
PCP prior to a 
patient’s first 
co-located 
mental health 
visit? 
There is no co-
located 
provider in the 
primary care 
practice 
 
 
 
 
0 
 
 
 
 
 
0-20% of the 
time 
 
 
 
 
 
 
1 
21-40% of the 
time 
 
 
 
 
 
 
2 
41-60% of the 
time 
 
 
 
 
 
 
3 
61-80% of the 
time 
 
 
 
 
 
 
4 
81-100% of the 
time 
 
 
 
 
 
 
5 
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C3 
How often does 
the referring 
PCP initiate 
oral 
communication 
(phone call, 
face-to-face 
conversation) 
with the co-
located mental 
health provider 
prior to a 
patient’s first 
co-located 
mental health 
visit? 
There is no co-
located 
provider in the 
primary care 
practice 
 
 
 
 
 
 
 
 
0 
0-20% of the 
time 
 
 
 
 
 
 
 
 
 
 
1 
21-40% of the 
time 
 
 
 
 
 
 
 
 
 
 
 
2 
41-60% of the 
time 
 
 
 
 
 
 
 
 
 
 
 
3 
61-80% of the 
time 
 
 
 
 
 
 
 
 
 
 
 
4 
81-100% of the 
time 
 
 
 
 
 
 
 
 
 
 
 
5 
How often does 
the co-located 
mental health 
provider send 
the following 
feedback to the 
PCP? 
There is no co-
located 
provider in the 
primary care 
practice 
 
 
0-20% of the 
 time 
 
 
 
 
21-40% of the 
time 
 
 
 
 
41-60% of the 
time 
 
 
 
 
61-80% of the 
time 
 
 
 
 
81-100% of the 
time 
 
 
 
 
C4 
Acknowledgem
ent of 
Appointment 
Kept by 
Referred 
Patient 
0 1 2 3 4 5 
C5 
Clarified 
Diagnosis for 
Referred 
Patient 
0 1 2 3 4 5 
C6 
Recommended 
Treatment Plan 
for Referred 
Patient 
0 1 2 3 4 5 
C7 
Adequate 
Response to a 
Referral 
Question 
0 1 2 3 4 5 
The next seven questions pertain to communication with the specialty mental health provider located outside of your 
practice. 
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C8 
What information 
is typically shared 
with the specialty 
mental health 
provider (located 
outside of the 
primary care 
office) by the 
referring PCP 
prior to a patient’s 
first specialty 
mental health 
visit? 
There is no 
information shared 
between the two 
providers prior to 
the first visit 
 
 
 
 
 
1 
A referral is made 
but no patient 
information is 
shared other than 
name 
 
 
 
 
 
2 
A referral is made 
and some patient 
information is 
shared 
 
 
 
 
 
 
3 
A referral is made 
and portions of 
medical chart are 
shared 
 
 
 
 
 
 
4 
A referral is made 
and full medical 
chart is shared 
 
 
 
 
 
 
 
5 
C9 
How often does 
the referring PCP 
initiate written 
communication 
(referral letter, 
email) with the 
specialty mental 
health provider 
prior to a patient’s 
first specialty 
mental health 
visit? 
0-20% of the time 
 
 
 
 
 
 
 
 
 
 
1 
21-40% of the 
time 
 
 
 
 
 
 
 
 
 
 
2 
41-60% of the 
time 
 
 
 
 
 
 
 
 
 
 
3 
61-80% of the 
time 
 
 
 
 
 
 
 
 
 
 
4 
81-100% of the 
time 
 
 
 
 
 
 
 
 
 
 
5 
C7 
How often does 
the referring PCP 
initiate oral 
communication 
(phone call, face-
to-face 
conversation) with 
the specialty 
mental health 
provider prior to a 
patient’s first 
specialty mental 
health visit? 
0-20% of the time 
 
 
 
 
 
 
 
 
 
 
1 
21-40% of the 
time 
 
 
 
 
 
 
 
 
 
 
2 
41-60% of the 
time 
 
 
 
 
 
 
 
 
 
 
3 
61-80% of the 
time 
 
 
 
 
 
 
 
 
 
 
4 
81-100% of the 
time 
 
 
 
 
 
 
 
 
 
 
5 
How often does 
the mental health 
specialty provider 
send the following 
feedback to the 
PCP? 
0-20% of the time 
 
 
 
21-40% of the 
time 
 
 
 
41-60% of the 
time 
 
 
 
61-80% of the 
time 
 
 
 
81-100% of the 
time 
 
 
 
C8 
Acknowledgemen
t of Appointment 
Kept by Referred 
Patient 
1 2 3 4 5 
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C9 
Clarified 
Diagnosis for 
Referred Patient 
1 2 3 4 5 
C10 
Recommended 
Treatment Plan 
for Referred 
Patient 
1 2 3 4 5 
C11 
Adequate 
Response to a 
Referral Question 
1 2 3 4 5 
VII.  PATIENT CARE 
The next three questions pertain to those patients for whom you refer to the co-located mental health provider. 
PC1 
After a patient 
is seen by a 
co-located 
mental health 
provider, how 
often is an 
individualized 
care plan 
created for the 
patient? 
There is no co-
located 
provider in the 
primary care 
practice 
 
 
 
 
0 
 
 
0-20% of the 
time 
 
 
 
 
 
1 
21-40% of the 
time 
 
 
 
 
2 
41-60% of the 
time 
 
 
 
 
3 
61-80% of the 
time 
 
 
 
 
4 
81-100% of the 
time 
 
 
 
 
5 
PC2 
For these 
patients, 
who takes 
responsibility 
for 
implementin
g the 
individualize
d care plan? 
There is no 
co-located 
provider in 
the primary 
care practice 
 
 
 
 
0 
 
No 
individualize
d care plan 
is created 
 
 
 
 
1 
The PCPs 
take full 
responsibility 
 
 
 
 
 
2 
There is 
some 
sharing but 
mostly the 
PCP takes 
responsibility 
 
 
 
3 
Both take 
joint 
responsibility 
 
 
 
 
 
 
4  
There is 
some 
sharing but 
mostly the 
mental 
health 
provider 
takes 
responsibility 
 
 
 
 
5 
 
 
The mental 
health/beha
vioral health 
provider 
takes full 
responsibilit
y 
 
 
6 
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PC3 
For these 
patients, 
who takes 
responsibility 
for following 
up on 
whether the 
individualize
d care plan 
is being 
followed? 
There is no 
co-located 
provider in 
the primary 
care practice 
 
 
 
 
 
 
0 
No 
individualize
d care plan 
is created 
 
 
 
 
 
 
 
1 
The PCPs 
take full 
responsibility 
 
 
 
 
 
 
 
 
2 
There is 
some 
sharing but 
mostly the 
PCP takes 
responsibility 
 
 
 
 
 
 
3 
Both take 
joint 
responsibility 
 
 
 
 
 
 
 
 
  
4 
There is 
some 
sharing but 
mostly the 
mental 
health 
provider 
takes 
responsibility 
 
 
 
 
 
5 
The mental 
health/beha
vioral health 
provider 
takes full 
responsibilit
y 
 
 
 
 
6 
Now we’ll switch to talking about patients referred to specialty mental health providers. 
PC4 
For your patients who are 
referred out to a specialty 
mental health provider, how 
knowledgeable are you that 
an individualized care plan is 
created for the patient? 
Not at all knowledgeable 
 
 
 
 
 
1 
Somewhat knowledgeable 
 
 
 
 
 
2 
Very knowledgeable 
 
 
 
 
 
3 
PC5 
Contingent 
upon 
knowledge 
of the plan, 
who takes 
responsibility 
for 
implementin
g the 
individualize
d care plan 
created? 
No 
knowledge of 
an 
individualize
d care plan 
 
 
 
 
 
0 
No 
individualize
d care plan 
is created 
 
 
 
 
 
1 
The PCPs 
take full 
responsibility 
 
 
 
 
 
 
2 
There is 
some 
sharing but 
mostly the 
PCP takes 
responsibility 
 
 
 
 
3 
Both take 
joint 
responsibility 
 
 
 
 
 
 
 
4  
There is 
some 
sharing but 
mostly the 
mental 
health 
provider 
takes 
responsibility 
 
 
 
5 
The mental 
health/behav
ioral health 
provider 
takes full 
responsibility 
 
 
 
6 
PC6 
Contingent 
on 
knowledge 
of the plan, 
who takes 
responsibility 
for following 
up on 
whether the 
individualize
d care plan 
is being 
followed? 
No 
knowledge of 
an 
individualize
d care plan 
 
 
 
 
 
 
 
0 
No 
individualize
d care plan 
is created 
 
 
 
 
 
 
1 
The PCPs 
take full 
responsibility 
 
 
 
 
 
 
 
2 
There is 
some 
sharing but 
mostly the 
PCP takes 
responsibility 
 
 
 
 
 
3 
Both take 
joint 
responsibility 
 
 
 
 
 
 
 
  
4 
There is 
some 
sharing but 
mostly the 
mental 
health 
provider 
takes 
responsibility 
 
 
 
 
5 
The mental 
health/behav
ioral health 
provider 
takes full 
responsibility 
 
 
 
 
6 
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VIII.  APPROPRIATE CARE PROCESSES 
The next five questions ask about appropriate care processes for patients.  We recognize that the term appropriate 
can have different meanings.  For the purpose of this survey, an appropriate care process includes (1) the use of 
established screening and/or diagnosis tools, (2) proper referral and/or treatment protocols, (3) adequate sharing of 
information between providers, and (4) appropriate follow-up  
How many 
elements of an 
appropriate care 
process are 
implemented at 
your practice for 
patients 
presenting with: 
No elements 
 
 
1 
1 element 
 
 
2 
2 elements 
 
 
3 
3 elements 
 
 
4 
4 elements 
 
 
5 
PC2 
Depression? 1 2 3 4 5 
PC3 
Anxiety? 1 2 3 4 5 
PC4 
ADHD/ADD? 1 2 3 4 5 
PC5 
Bipolar Disorder? 1 2 3 4 5 
PC6 
Substance 
Abuse? 1 2 3 4 5 
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Appendix E. Integration Activities Assessment Tool 
Pilot Site 
    
Your Name 
   
City 
        
Title   
    
              
Quarter 
    
Fiscal Year 
      
      
Activity Wk 
1 
Wk 
2 
Wk 
3 
Wk 
4 
Wk 
5 
Wk 
6 
Wk 
7 
Wk 
8 
Wk 
9 
Wk 
10 
Wk 
11 
Wk 
12 
Wk 
13 
(1) Potential ICARE target 
population (total population 
eligible to receive services 
from ICARE – active charts 
in ICARE practices) 
                          
(2) Number of Potential 
ICARE Patients (above) that 
are screened for mental 
health services by ICARE 
staff 
             
(3) Number of potential 
ICARE patients (above) that 
are referred to ICARE staff 
for mental health services  
                          
(4) # of mental health 
appointments conducted by 
ICARE providers/staff 
                          
(5) # of mental health 
appointments referred out 
by ICARE providers/staff 
                          
(5a) # of appointments in #5 
referred to the LME              
(5b) # of appointments in #5 
referred to other mental 
health providers 
             
(6) # of contacts 
(consultation/ 
collaboration/communication) 
between ICARE 
provider/case manager and 
primary care office 
staff/physicians that were 
spent discussing patients 
                          
(7) # of contacts 
(consultation/collaboration/ 
communication) occurring 
directly between ICARE 
provider/case manager and 
specialty mental health 
providers 
             
(8) # of contacts 
(consultation/collaboration) 
between ICARE 
provider/case manager and 
the LME 
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Appendix F. Semi-Structured Interview Guide 
1. What are your perceptions of the overall implementation of ICARE? 
2. What obstacles have you encountered while implementing ICARE? 
3. What facilitators have you encountered while implementing ICARE? 
4. Do you think the program has been successful? Unsuccessful?  Why? 
5. What changes have you been able to sustain? (Ask in second interview only).  Why? 
6. What would you change if you had it to do over again? 
7. Do you believe it has improved the care that patients have received?  What pieces of ICARE 
have made a direct contribution to that change? 
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Appendix G. Patient Focus Group Guide 
1. Discuss the mental health care you have been receiving over the last (time period ICARE has 
been implemented). 
2. How has this care changed, as compared to your mental health care prior to ICARE 
implementation? 
3. What are some of the things that you like about your health care and mental health care at 
(ICARE primary care clinic)? 
4. What are some of the things you don’t’ like about your health care and mental health care 
at (ICARE primary care clinic)? 
5. What would you change about your care at (ICARE primary care clinic)? 
6. Would you say that your mental health care has gotten better or worse since (time period 
when ICARE was implemented)? 
 
